Literature DB >> 12033441

A2E and blue light in the retina: the paradigm of age-related macular degeneration.

Hamdy Shaban1, Christoph Richter.   

Abstract

The photoreceptors in the retina, designed to initiate the cascade of events which link the incoming light to the sensation of 'vision', are susceptible to damage by light, particularly blue light. The damage can lead to cell death and diseases. The turnover of retinal, an essential element of the visual process, is the basis of the events that lead to damage. Free retinal, absorbing in the blue region of the visible spectrum, is phototoxic, and is a precursor of the (photo)toxic compound A2E, which specifically targets cytochrome oxidase and thereby induces cell death by apoptosis. Cell death induced by A2E in the dark is prevented by negatively charged phospholipids. The blue light-filtering molecules lutein and zeaxanthin are tailor-made substances protecting the retina. In vitro, they protect cytochrome oxidase against the permanent damage caused by A2E in combination with light. These novel findings should enable us to prevent or cure the dry form of age-related macular degeneration, the leading cause of severe visual impairment in humans living in developed countries.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12033441     DOI: 10.1515/BC.2002.054

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  9 in total

1.  Spectroscopic and morphological studies of human retinal lipofuscin granules.

Authors:  Nicole M Haralampus-Grynaviski; Laura E Lamb; Christine M R Clancy; Christine Skumatz; Janice M Burke; Tadeusz Sarna; John D Simon
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-28       Impact factor: 11.205

2.  Nitrate-nitrogen levels in rural drinking water: Is there an association with age-related macular degeneration?

Authors:  Barbara E K Klein; Jane A McElroy; Ronald Klein; Kerri P Howard; Kristine E Lee
Journal:  J Environ Sci Health A Tox Hazard Subst Environ Eng       Date:  2013       Impact factor: 2.269

3.  Vitamin D status and early age-related macular degeneration in postmenopausal women.

Authors:  Amy E Millen; Rick Voland; Sherie A Sondel; Niyati Parekh; Ronald L Horst; Robert B Wallace; Gregory S Hageman; Rick Chappell; Barbara A Blodi; Michael L Klein; Karen M Gehrs; Gloria E Sarto; Julie A Mares
Journal:  Arch Ophthalmol       Date:  2011-04

4.  Analysis from the perspective of cilia: the protective effect of PARP inhibitors on visual function during light-induced damage.

Authors:  Lin Che; Jing-Yao Song; Yan Lou; Guang-Yu Li
Journal:  Int Ophthalmol       Date:  2019-12-04       Impact factor: 2.031

5.  Eye disease resulting from increased use of fluorescent lighting as a climate change mitigation strategy.

Authors:  Helen L Walls; Kelvin L Walls; Geza Benke
Journal:  Am J Public Health       Date:  2011-10-20       Impact factor: 9.308

6.  Possible influences of lutein and zeaxanthin on the developing retina.

Authors:  J Paul Zimmer; Billy R Hammond
Journal:  Clin Ophthalmol       Date:  2007-03

7.  Genetic evidence for role of carotenoids in age-related macular degeneration in the Carotenoids in Age-Related Eye Disease Study (CAREDS).

Authors:  Kristin J Meyers; Julie A Mares; Robert P Igo; Barbara Truitt; Zhe Liu; Amy E Millen; Michael Klein; Elizabeth J Johnson; Corinne D Engelman; Chitra K Karki; Barbara Blodi; Karen Gehrs; Lesley Tinker; Robert Wallace; Jennifer Robinson; Erin S LeBlanc; Gloria Sarto; Paul S Bernstein; John Paul SanGiovanni; Sudha K Iyengar
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-01-29       Impact factor: 4.799

Review 8.  Lutein, zeaxanthin, and meso-zeaxanthin: The basic and clinical science underlying carotenoid-based nutritional interventions against ocular disease.

Authors:  Paul S Bernstein; Binxing Li; Preejith P Vachali; Aruna Gorusupudi; Rajalekshmy Shyam; Bradley S Henriksen; John M Nolan
Journal:  Prog Retin Eye Res       Date:  2015-11-02       Impact factor: 21.198

9.  The specific binding of retinoic acid to RPE65 and approaches to the treatment of macular degeneration.

Authors:  Deviprasad R Gollapalli; Robert R Rando
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-24       Impact factor: 11.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.